Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).
WASHINGTON, D.C. – Cancer survivors, researchers and advocates, including Dr.
A new bill that would improve access to clinical trials was recently introduced in the U.S. Senate. Sponsored by Senators Tim Scott (R-S.C.) and Mark Warner (D-Va.), the Clinical Trial Modernization Act (S. 4440) would help reduce cost and geographic barriers, making it easier for patients to take part in clinical trials. U.S. Representatives Raul Ruiz (D-Calif.) and August Pfluger (R-Texas) introduced the House version (H.R. 3521) of this legislation in May 2025.
As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.
MONTGOMERY, Ala. – In a show of unity among scientists across Alabama, more than 50 cancer researchers from multiple universities will gather for a symposium at the State House in Montgomery on Tuesday, March 31.
Earlier today, legislation was introduced in the New Jersey Assembly as a companion to Senate Bill 773, proposing to increase the state’s investment in the New Jersey Commission on Cancer Research (NJCCR). Assembly Bill 4579 would establish a dedicated, non-lapsing investment in the amount of $10 million, utilizing a greater proportion of the state tobacco tax revenue to do so. With bills now moving in both chambers, survivors and advocates with the American Cancer Society Cancer Action Network (ACS CAN) are encouraged by the growing momentum to expand support for cancer research and accelerate lifesaving innovations.
Following today’s health-Medicaid budget hearing, more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on lawmakers to preserve access to biomarker testing, a priority shared by over 100 organizations statewide. Advocates also expressed hope that the one‑house and final budgets will include meaningful investments in cancer prevention and early detection.